133 related articles for article (PubMed ID: 21622158)
1. EPO reduces reactive gliosis and stimulates neurotrophin expression in Muller cells.
Hu LM; Luo Y; Zhang J; Lei X; Shen J; Wu Y; Qin M; Unver YB; Zhong Y; Xu GT; Li W
Front Biosci (Elite Ed); 2011 Jun; 3(4):1541-55. PubMed ID: 21622158
[TBL] [Abstract][Full Text] [Related]
2. EPO protects Müller cell under high glucose state through BDNF/TrkB pathway.
Wang P; Xia F
Int J Clin Exp Pathol; 2015; 8(7):8083-90. PubMed ID: 26339375
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.
Zhang J; Wu Y; Jin Y; Ji F; Sinclair SH; Luo Y; Xu G; Lu L; Dai W; Yanoff M; Li W; Xu GT
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):732-42. PubMed ID: 18235022
[TBL] [Abstract][Full Text] [Related]
4. Carbamylated erythropoietin mediates retinal neuroprotection in streptozotocin-induced early-stage diabetic rats.
Liu X; Zhu B; Zou H; Hu D; Gu Q; Liu K; Xu X
Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1263-72. PubMed ID: 25725621
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin exerts a neuroprotective function against glutamate neurotoxicity in experimental diabetic retina.
Gu L; Xu H; Wang F; Xu G; Sinha D; Wang J; Xu JY; Tian H; Gao F; Li W; Lu L; Zhang J; Xu GT
Invest Ophthalmol Vis Sci; 2014 Oct; 55(12):8208-22. PubMed ID: 25335981
[TBL] [Abstract][Full Text] [Related]
6. Time-dependent changes in hypoxia- and gliosis-related factors in experimental diabetic retinopathy.
Gu L; Xu H; Zhang C; Yang Q; Zhang L; Zhang J
Eye (Lond); 2019 Apr; 33(4):600-609. PubMed ID: 30401898
[TBL] [Abstract][Full Text] [Related]
7. Different aspects of gliosis in retinal Muller glia can be induced by CNTF, insulin, and FGF2 in the absence of damage.
Fischer AJ; Omar G; Eubanks J; McGuire CR; Dierks BD; Reh TA
Mol Vis; 2004 Dec; 10():973-86. PubMed ID: 15623987
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin Protects Retinal Cells in Diabetic Rats Through Upregulating ZnT8 via Activating ERK Pathway and Inhibiting HIF-1α Expression.
Xu G; Kang D; Zhang C; Lou H; Sun C; Yang Q; Lu L; Xu GT; Zhang J; Wang F
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8166-78. PubMed ID: 26720469
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
[TBL] [Abstract][Full Text] [Related]
10. Expression of ciliary neurotrophic factor activated by retinal Müller cells in eyes with NMDA- and kainic acid-induced neuronal death.
Honjo M; Tanihara H; Kido N; Inatani M; Okazaki K; Honda Y
Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):552-60. PubMed ID: 10670488
[TBL] [Abstract][Full Text] [Related]
11. Epo inhibits the fibrosis and migration of Müller glial cells induced by TGF-β and high glucose.
Luo W; Hu L; Li W; Xu G; Xu L; Zhang C; Wang F
Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):881-90. PubMed ID: 26907931
[TBL] [Abstract][Full Text] [Related]
12. Attenuated glial reactions and photoreceptor degeneration after retinal detachment in mice deficient in glial fibrillary acidic protein and vimentin.
Nakazawa T; Takeda M; Lewis GP; Cho KS; Jiao J; Wilhelmsson U; Fisher SK; Pekny M; Chen DF; Miller JW
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2760-8. PubMed ID: 17525210
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats.
Mitsuhashi J; Morikawa S; Shimizu K; Ezaki T; Yasuda Y; Hori S
Exp Eye Res; 2013 Jan; 106():64-73. PubMed ID: 23178551
[TBL] [Abstract][Full Text] [Related]
14. Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects.
García-Ramírez M; Hernández C; Simó R
Diabetes Care; 2008 Jun; 31(6):1189-94. PubMed ID: 18332162
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin protects the inner blood-retinal barrier by inhibiting microglia phagocytosis via Src/Akt/cofilin signalling in experimental diabetic retinopathy.
Xie H; Zhang C; Liu D; Yang Q; Tang L; Wang T; Tian H; Lu L; Xu JY; Gao F; Wang J; Jin C; Li W; Xu G; Xu GT; Zhang J
Diabetologia; 2021 Jan; 64(1):211-225. PubMed ID: 33104828
[TBL] [Abstract][Full Text] [Related]
16. Involvement of ciliary neurotrophic factor in early diabetic retinal neuropathy in streptozotocin-induced diabetic rats.
Ma M; Xu Y; Xiong S; Zhang J; Gu Q; Ke B; Xu X
Eye (Lond); 2018 Sep; 32(9):1463-1471. PubMed ID: 29795129
[TBL] [Abstract][Full Text] [Related]
17. Systemic administration of erythropoietin inhibits retinopathy in RCS rats.
Shen W; Chung SH; Irhimeh MR; Li S; Lee SR; Gillies MC
PLoS One; 2014; 9(8):e104759. PubMed ID: 25119659
[TBL] [Abstract][Full Text] [Related]
18. BMP4 and CNTF are neuroprotective and suppress damage-induced proliferation of Müller glia in the retina.
Fischer AJ; Schmidt M; Omar G; Reh TA
Mol Cell Neurosci; 2004 Dec; 27(4):531-42. PubMed ID: 15555930
[TBL] [Abstract][Full Text] [Related]
19. The Effects of Sonic Hedgehog on Retinal Müller Cells Under High-Glucose Stress.
Zhao X; Li Y; Lin S; Cai Y; Zhang J; Yu X; Yang H; Yang L; Chen X; Luo Y; Lu L
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2773-82. PubMed ID: 25813994
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin protects outer blood-retinal barrier in experimental diabetic retinopathy by up-regulating ZO-1 and occludin.
Zhang C; Xie H; Yang Q; Yang Y; Li W; Tian H; Lu L; Wang F; Xu JY; Gao F; Wang J; Jin C; Xu G; Xu GT; Zhang J
Clin Exp Ophthalmol; 2019 Dec; 47(9):1182-1197. PubMed ID: 31483932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
